All In Biotech

Drug Trial Radar · NCT02655354

A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity

Last checked: Nov 19, 2026Latest source record: Jul 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 635 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

635

Actual

Start

Oct 2015

Primary completion

Nov 2019

Study completion Nov 2019

Sponsor

Lead sponsor
University of WashingtonAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institutes of Health (NIH); National Institute of Mental Health (NIMH); National Institute on Alcohol Abuse and Alcoholism (NIAAA)
First posted
Jan 14, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The overarching goal of this UH2-UH3 proposal is to work with the NIH Health Care Systems Research Collaboratory to develop and implement a large scale, cluster randomized pragmatic clinical trial demonstration project that directly informs national trauma care system policy targeting injured patients with presentations of Posttraumatic Stress Disorder (PTSD) and related comorbidity. Each year in the United States (US), over 30 million individuals present to trauma centers, emergency departments, and other acute care medical settings for the treatment of physical injuries. Multiple chronic conditions including enduring PTSD, alcohol and drug use problems, depression and associated suicidal ideation, pain and somatic symptom amplification, and chronic medical conditions (e.g., hypertension, coronary artery disease, diabetes, and pulmonary diseases) are endemic among physical trauma survivors with and without traumatic brain injuries (TBI). Evidence-based, collaborative care/care management treatment models for PTSD and related comorbidities exist. These care management models have the potential to be flexibly implemented in order to prevent the development of chronic PTSD and depressive symptoms, alcohol use problems, and enduring physical disability in survivors of both TBI and non-TBI injuries; care management models may also be effective in mitigating the impact of the acute injury event on symptom exacerbations in the large subpopulation of injury survivors who already carry a substantial pre-injury burden of multiple chronic medical conditions.

Conditions

  • Posttraumatic Stress Disorder
  • Depression
  • Alcohol-Related Disorders
  • Suicidal Ideation
  • Substance-Related Disorders
  • Mild Cognitive Impairment
  • Quality of Life
  • Pain
  • Wounds and Injury
  • Brain Injuries
  • Chronic Disease

Interventions

  • Motivational InterviewingBehavioral

  • Cognitive Behavioral Therapy ElementsBehavioral

  • Care ManagementBehavioral

  • FluoxetineDrug

    Anti-depressant

  • FluvoxamineDrug

    Anti-depressant

  • ParoxetineDrug

    Anti-depressant

  • SertralineDrug

    Anti-depressant

  • CitalopramDrug

    Anti-depressant

  • VenlafaxineDrug

    Anti-depressant

  • DuloxetineDrug

    Anti-depressant

  • MirtazapineDrug

    Anti-depressant

  • DiphenhydramineDrug

    Sleep medication

  • TrazodoneDrug

    Sleep medication

  • PrazosinDrug

    Sleep medication

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline PTSD Checklist- Civilian (PCL-C) Over the Course of the Year After InjuryTime frame: Baseline, 3-month, 6-month, 12-month
  2. Change From Baseline Patient Health Questionnaire 9 Item Depression Scale Over the Course of the Year After InjuryTime frame: Baseline, 3-month, 6-month, 12-month
  3. Change From Baseline Alcohol Use Disorders Identification Over the Course of the Year After InjuryTime frame: Baseline, 3-month, 6-month, 12-month
  4. Change From Baseline Short Form (SF)-12/36 Physical Function Over the Course of the Year After InjuryTime frame: Baseline, 3-month, 6-month, 12-month

Locations

24 sites in 1 country. Site status is shown where the registry gives one.

  • Honor Health

    Scottsdale, Arizona

  • Cedars Sinai

    Beverly Hills, California

  • U.C. Davis

    Sacramento, California

  • Santa Clara Valley Medical Center

    San Jose, California

  • U.C.L.A. Harbor

    Torrance, California

  • Hartford Hospital

    Hartford, Connecticut

  • Georgia Regents

    Augusta, Georgia

  • Eskenazi Health

    Indianapolis, Indiana

  • University of Iowa

    Iowa City, Iowa

  • University of Kentucky

    Lexington, Kentucky

  • Louisiana State University

    New Orleans, Louisiana

  • Regions Hospital

    Saint Paul, Minnesota

  • University of Rochester

    Rochester, New York

  • Jacobi Medical Center

    The Bronx, New York

  • Wake Forest

    Winston-Salem, North Carolina

  • University of Cincinnati

    Cincinnati, Ohio

  • Ohio State University

    Columbus, Ohio

  • Baylor Health Care System

    Dallas, Texas

  • UT Southwestern Medical Center

    Dallas, Texas

  • University of Texas Medical Branch at Galveston

    Galveston, Texas

  • The University of Utah

    Salt Lake City, Utah

  • The University of Vermont

    Burlington, Vermont

  • Inova Trauma Center

    Falls Church, Virginia

  • The University of Wisconsin Madison

    Madison, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.